Skip to Content

New Drug Approvals Archive - September 2003

September 2003

Seasonale (ethinyl estradiol and levonorgestrel) Tablets

Date of Approval: September 5, 2003
Company: Barr Laboratories
Treatment for: Contraception

Seasonale (ethinyl estradiol and levonorgestrel) is an extended-cycle oral contraceptive.

Seasonale Barr Laboratories - Treatment for Prevention of Pregnancy

Riomet (metformin hydrochloride) Oral Solution

Date of Approval: September 11, 2003
Company: Ranbaxy Pharmaceuticals Inc.
Treatment for: Diabetes Type 2

Riomet is an oral solution formulation of the antihyperglycemic drug metformin indicated for the treatment of type 2 diabetes.

Riomet Ranbaxy Pharmaceuticals Inc. - Treatment for Type 2 Diabetes

Cubicin (daptomycin ) Injection

Date of Approval: September 12, 2003
Company: Cubist Pharmaceuticals
Treatment for: Skin and Structure Infection, Bacteremia

Cubicin (daptomycin) is a lipopeptide antibacterial indicated for the treatment of complicated skin and skin structure infections (cSSSI) and staphylococcus aureus bloodstream infections (bacteremia).

Cubicin Cubist Pharmaceuticals - Treatment for Skin Infections

New Drug Approvals Archive

2018January, February, March, April, May, June, July, August, September, October

2017January, February, March, April, May, June, July, August, September, October, November, December

2016January, February, March, April, May, June, July, August, September, October, November, December

2015January, February, March, April, May, June, July, August, September, October, November, December

2014January, February, March, April, May, June, July, August, September, October, November, December

2013January, February, March, April, May, June, July, August, September, October, November, December

2012January, February, March, April, May, June, July, August, September, October, November, December

2011January, February, March, April, May, June, July, August, October, November, December

2010January, February, March, April, May, June, July, August, September, October, November, December

2009January, February, March, April, May, June, July, August, September, October, November, December

2008January, February, March, April, May, June, July, August, September, October, November, December

2007January, February, March, April, May, June, July, August, September, October, November, December

2006January, February, March, April, May, June, July, August, September, October, November, December

2005January, February, March, April, May, June, July, August, September, October, November, December

2004January, February, March, April, May, June, July, August, September, October, November, December

2003January, February, March, April, May, June, July, August, September, October, November, December

2002January, February, April, May, July, August, September, October, November, December

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Recently Approved

Talzenna Talzenna (talazoparib) is an oral poly ADP ribose polymerase (PARP) inhibitor indicated for the...
Yutiq Yutiq (fluocinolone acetonide) is a corticosteroid intravitreal implant indicated for the treatment...
Tegsedi Tegsedi (inotersen) is an antisense oligonucleotide inhibitor of the transthyretin (TTR) protein...
Revcovi Revcovi (elapegademase-lvlr) is a recombinant adenosine deaminase indicated for the treatment of...

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com Pill Reminder

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.